Skip to main content

Clonazepam

FDA recalls

2 rows

DateCompany and reasonClass
Nov 17, 2024Endo USA, Inc.
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.		Class I · Ongoing
Jul 9, 2024Endo Pharmaceuticals, Inc.
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.		Class I · Terminated

← Back to Clonazepam

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).